Hungary ranks third in the European Union in corporate pharmaceutical R&D expenditure as a percentage of GDP.
85% confidence
HealthHungary
Omissions
The claim uses 2022 data (most recent available from EFPIA), which may not reflect the most current situation at the time of the speech (January 2026)
The ranking refers specifically to pharmaceutical industry R&D investment as a share of GDP, not total corporate R&D expenditure across all sectors
The source for this ranking is EFPIA (European Federation of Pharmaceutical Industries and Associations), not Eurostat or an official EU statistical office
Hungary's overall R&D expenditure (all sectors) is significantly lower at around 1.38% of GDP (2023 data)
Sources
PrimaryEFPIA - The Pharmaceutical Industry in Figures 2024Hungary ranked 3rd in EU for pharmaceutical industry R&D investment as percentage of GDP at 1.06% (2022 data). Denmark was 1st at 2.04%, Belgium 2nd at 1.35%.